Cargando…

Safety of add-on sulfonylurea therapy in patients with type 2 diabetes using metformin: a population-based real-world study

INTRODUCTION: Metformin is the initial oral antihyperglycemic agent (OHA) of choice for most patients with type 2 diabetes (T2D). However, more than one agent is often required for optimal glucose control. As the choice of preferred second OHAs is less well defined, we sought to compare the real-wor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hougen, Ingrid, Whitlock, Reid H, Komenda, Paul, Rigatto, Claudio, Clemens, Kristin K, Tangri, Navdeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Cardiovascular and Metabolic Risk
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718392/ https://www.ncbi.nlm.nih.gov/pubmed/34969692 http://dx.doi.org/10.1136/bmjdrc-2021-002352

Ejemplares similares

Hyperkalemia and its Association With Mortality, Cardiovascular Events, Hospitalizations, and Intensive Care Unit Admissions in a Population-Based Retrospective Cohort
por: Hougen, Ingrid, et al.
Publicado: (2021)

Hyperinsulinemia and sulfonylurea use are independently associated with left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus with suboptimal blood glucose control
por: Inoue, Tomoaki, et al.
Publicado: (2016)

Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
por: Lee, Christine G., et al.
Publicado: (2021)

Long-term effect of intensive lifestyle intervention on cardiovascular risk factors in patients with diabetes in real-world clinical practice: a 5-year longitudinal study
por: Hamdy, Osama, et al.
Publicado: (2017)

PERsistent Sitagliptin treatment & Outcomes (PERS&O 2.0) study, long-term results: a real-world observation on DPP4-inhibitor effectiveness
por: Bossi, Antonio Carlo, et al.
Publicado: (2020)

Effect of post-discharge virtual wards on improving outcomes in heart failure and non-heart failure populations: A systematic review and meta-analysis
por: Uminski, Kelsey, et al.
Publicado: (2018)

Long-term effect of intensive lifestyle intervention on cardiometabolic risk factors and microvascular complications in patients with diabetes in real-world clinical practice: a 10-year longitudinal study
por: Tomah, Shaheen, et al.
Publicado: (2023)

Validation of the Kidney Failure Risk Equation in Manitoba
por: Whitlock, Reid H., et al.
Publicado: (2017)

A Cost-Minimization Analysis of Nurse-Led Virtual Case Management in Late-Stage CKD
por: Ferguson, Thomas W., et al.
Publicado: (2020)

Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors
por: Ren, Hongru, et al.
Publicado: (2022)

Long term health outcomes in patients with a history of myocardial infarction: A population based cohort study
por: Tangri, Navdeep, et al.
Publicado: (2017)

Magnitude of the Potential Screening Gap for Fabry Disease in Manitoba: A Population-Based Retrospective Cohort Study
por: Whitlock, Reid H., et al.
Publicado: (2023)

The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) trial
por: Lexis, Chris P H, et al.
Publicado: (2015)

Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life
por: Longato, Enrico, et al.
Publicado: (2020)

Casual blood glucose and subsequent cardiovascular disease and all-cause mortality among 159 731 participants in Cohort of Norway (CONOR)
por: Riise, Hilde Kristin Refvik, et al.
Publicado: (2021)

Metabolic characteristics of Africans with normal glucose tolerance and elevated 1-hour glucose: insight from the Africans in America study
por: Briker, Sara M, et al.
Publicado: (2020)

Safety of medical compression stockings in patients with diabetes mellitus or peripheral arterial disease
por: Rother, Ulrich, et al.
Publicado: (2020)

Infant Body Composition and Adipokine Concentrations in Relation to Maternal Gestational Weight Gain
por: Estampador, Angela C., et al.
Publicado: (2014)

Mortality risk for women on chronic hemodialysis differs by age
por: Sood, Manish M, et al.
Publicado: (2014)

Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease
por: Birukov, Anna, et al.
Publicado: (2022)

Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials
por: Tuttle, Katherine R., et al.
Publicado: (2022)

Cost-Utility of Dialysis in Canada: Hemodialysis, Peritoneal Dialysis, and Nondialysis Treatment of Kidney Failure
por: Ferguson, Thomas W., et al.
Publicado: (2020)

Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial
por: Shestakova, Marina, et al.
Publicado: (2023)

Use of Wearable and Wireless Technology in Real-World Clinical Settings to Improve Patient Outcomes in Chronic Kidney Disease: A Mixed Methods Pilot Prospective Trial
por: Pieroni, Domenic, et al.
Publicado: (2023)

Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial
por: Dagogo-Jack, Samuel, et al.
Publicado: (2021)

Risk of Kidney Failure, Death, and Cardiovascular Events After Lower Limb Complications in Patients With CKD
por: Li, Kevin, et al.
Publicado: (2020)

A before and after cross-sectional analysis of a public health campaign to increase kidney health awareness in a Canadian province
por: Ryz, Krista, et al.
Publicado: (2015)

A retrospective review of the two-step tuberculin skin test in dialysis patients
por: Foster, Rukhsana, et al.
Publicado: (2016)

Prevalence of the Metabolic Syndrome Among a Racially/Ethnically Diverse Group of U.S. Eighth-Grade Adolescents and Associations With Fasting Insulin and Homeostasis Model Assessment of Insulin Resistance Levels
Publicado: (2008)

Glucose Intolerance in Pregnancy and Future Risk of Pre-Diabetes or Diabetes
por: Retnakaran, Ravi, et al.
Publicado: (2008)

Changes in Triglyceride Levels Over Time and Risk of Type 2 Diabetes in Young Men
por: Tirosh, Amir, et al.
Publicado: (2008)

Risk Prediction of Cardiovascular Disease in Type 2 Diabetes: A risk equation from the Swedish National Diabetes Register
por: Cederholm, Jan, et al.
Publicado: (2008)

Changes in Risk Variables of Metabolic Syndrome Since Childhood in Pre-Diabetic and Type 2 Diabetic Subjects: The Bogalusa Heart Study
por: Nguyen, Quoc Manh, et al.
Publicado: (2008)

Alcohol Consumption, Mediating Biomarkers, and Risk of Type 2 Diabetes Among Middle-Aged Women
por: Beulens, Joline W.J., et al.
Publicado: (2008)

Predicting Diabetes: Clinical, Biological, and Genetic Approaches: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR)
por: Balkau, Beverley, et al.
Publicado: (2008)

Normal Glucose Values Are Associated With a Lower Risk of Mortality in Hospitalized Patients
por: Bruno, Alberto, et al.
Publicado: (2008)

Hyperinsulinemia in African-American Adolescents Compared With Their American White Peers Despite Similar Insulin Sensitivity: A reflection of upregulated β-cell function?
por: Hannon, Tamara S., et al.
Publicado: (2008)

Sex Differences in Diabetes Risk and the Effect of Intensive Lifestyle Modification in the Diabetes Prevention Program
por: Perreault, Leigh, et al.
Publicado: (2008)

Retinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome
por: Hutchison, Samantha K., et al.
Publicado: (2008)

Insulin Resistance and Hyperinsulinemia: You can't have one without the other
por: Kim, Sun H., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_2kjv4aatik7lcha45edi8ph2i2